EFFECT OF ATORVASTATIN THERAPY IN DIFFERENT DOSES ON ENDOTHELIAL PROGENITOR CELLS AND ANGIOGENIC FACTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE

Endothelial progenitor cells (EPC) research is a promising trend in cardiology and angiology, since they are actively involved in the vascular endothelium reparation and angiogenesis. Reduction of EPC counts was demonstrated as an independent predictor of cardiovascular morbidity and mortality. The